How is the NovoCure Ltd today?

The NovoCure Ltd today is trading in the down by -10.83% at 17.04.

How has NovoCure Ltd performed historically?

The NovoCure Ltd is currently trading down -10.83% on an intraday basis in the past week the index fell -8.09%. The index has been down -10.64% in the past quarter and fell -22.58% in the past year. You can view this in the overview section.

What is NovoCure Ltd Annual Revenue?

NovoCure Ltd Annual Revenue rose 18.82%, in the last year to $605.22 M. Its sector's average revenue growth for the last fiscal year was 9.83%.

What is NovoCure Ltd Annual Net Profit?

NovoCure Ltd Annual Net Profit rose 18.55% in the last year to $168.63 M. Its sector's average net profit growth for the last fiscal year was 10.05%.

What is NovoCure Ltd Price to Earning Ratio?

NovoCure Ltd Price to Earning Ratio is -11.57, which is negative.

What is NovoCure Ltd Stock Price?

NovoCure Ltd Stock Price fell 22.58% and underperformed its sector by 32.02% in the past year.

What is NovoCure Ltd Quarterly Revenue?

NovoCure Ltd Quarterly Revenue rose 11.91% YoY to $154.99 M. Its sector's average revenue growth YoY for the quarter was 8.35%.

What is NovoCure Ltd Quarterly Net profit?

NovoCure Ltd Quarterly Net profit rose 11.46% YoY to $34.32 M. Its sector's average net profit growth YoY for the quarter was 58.99%.

What is NovoCure Ltd Debt to Equity Ratio?

NovoCure Ltd Debt to Equity Ratio of 1.9 is higher than 1. This implies that company assets are financed through debt.

What is NovoCure Ltd Return on Equity(ROE)?

NovoCure Ltd Return on Equity(ROE) for the last financial year was -46.67%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is NovoCure Ltd Mutual Fund Holding?

NovoCure Ltd Mutual Fund Holding decreased by 2.16% in the last quarter to 71.35.

What is NovoCure Ltd Promoter Share Holding?

NovoCure Ltd Promoter Share Holding increased by 0.5% in the most recent quarter to 2.25%.

What is NovoCure Ltd Interest Coverage Ratio?

NovoCure Ltd Interest Coverage Ratio is -11.68, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is NovoCure Ltd Institutional Holding?

NovoCure Ltd Institutional Holding increased by 3.36% in the last quarter to 86.95.

NovoCure Ltd XNAS: NVCR

NovoCure Ltd Live Share Price Today, Share Analysis and Chart

Name: NovoCure Ltd: Is Infosys Ltd. worth buying?
Item: NovoCure Ltd
Rating: 1.4543195
Author: Trendlyne DVM scores

Momentum Trap

about

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, fo...

17.04 -2.07 (-10.83%)

50.07% Fall from 52W High

2.6M XNAS Volume

High volume+loss today

XNAS 02 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for NovoCure Ltd is on 05 Jun 2025 for the purpose of NovoCure Ltd Annual General Meeting for 2025 See details

Low Financial Strength

27.8 / 100

Expensive Valuation

11.5 / 100

Technically Neutral

49.3 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 91%

7 analysts

NovoCure Ltd Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

NovoCure Ltd Live Share Price Today, Share Analysis and Chart

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, fo...

50.07% Fall from 52W High

High volume+loss today

SWOT Analysis

NovoCure Ltd Live Price Chart

NovoCure Ltd FAQ

How is NovoCure Ltd today?

NovoCure Ltd today is trading in the red, and is down by -10.83% at 17.04.

How has NovoCure Ltd performed historically?

NovoCure Ltd is currently trading down -10.83% on an intraday basis. In the past week the stock fell -8.09%. stock has been down -10.64% in the past quarter and fell -22.58% in the past year. You can view this in the overview section.